Speaker illustration

undefined undefined undefined

Variability of left ventricular ejection fraction in cardiovascular patients with and without heart failure

Event: ESC Congress 2025

Topic: Epidemiology, Prognosis, Outcome

Session: Characterising subpopulations in heart failure

Thumbnail

Analysis of left atrial thrombus in atrial flutter and atrial fibrillation

Event: ESC Congress 2025

Topic: Macro-Reentrant Atrial Tachycardia and Flutter

Session: Anticoagulation in atrial fibrillation: real-world experience

Thumbnail

Efficacy and safety of antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation depending on gender: a subanalysis of CANT II Study

Event: ESC Congress 2023

Topic: Antiarrhythmic Drug Treatment

Session: Cardioversion, antiarrhythmics and antithrombotic management of atrial fibrillation

Thumbnail

Clinical characteristics and risk factors of in-hospital mortality among patients undergoing percutaneous pericardiocentesis

Event: ESC Congress 2023

Topic: Complications

Session: Coronary diagnostics and interventions

Thumbnail

Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation and atrial flutter: insights from the LATTEE registry

Event: ESC Congress 2022

Topic: Oral Anticoagulation

Session: Stroke prevention in atrial fibrillation

Thumbnail

Pharmacological cardioversion of recent-onset atrial fibrillation in patients with chronic kidney disease: sub-analysis of the CANT Study

Event: ESC Congress 2021 - The Digital Experience

Topic: Rhythm Control, Cardioversion

Session: Atrial fibrillation e-posters

Thumbnail

CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis

Event: ESC Congress 2021 - The Digital Experience

Topic: Autoimmune/Chronic Inflammatory Disorders and Heart Disease

Session: Cardiovascular Disease in Special Populations ePosters

Thumbnail

Antazoline for pharmacological cardioversion of atrial fibrillation: the results of the high-volume multicenter CANT study

Event: ESC Congress 2020

Topic: Rhythm Control, Cardioversion

Session: Atrial Fibrillation ePosters

Thumbnail

Managed Care after Acute Myocardial Infarction (MC-AMI) reduces MACE by 45% in 3-month follow-up - results form Poland's National Health Fund program of post-MI care. A single center analysis

Event: ESC Congress 2019

Topic: Secondary Prevention

Session: Risk factors and prevention

Thumbnail

Efficacy of comprehensive Managed Care after Acute Myocardial Infarction (MC-AMI) in a long-term follow-up - preliminary experience of a single high-volume center.

Event: ESC Congress 2019

Topic: Secondary Prevention

Session: Risk factors and prevention

Thumbnail

ESC 365 is supported by